New collaborative study on the effects of Near Infrared Photobiomodulation in Parkinson’s disease
The Woods Neuromodulation Lab will participate in a new collaborative grant funded by a Parkinson’s Foundation Impact Award to test a novel, low-cost intervention for improving motor skills and cognition in individuals with Parkinson disease at the Fixel Institute for Neurological Diseases at UF Health.
The project is led by Dawn Bowers, Ph.D., director of the UF Cognitive Neuroscience Laboratory, and her colleagues Christopher W. Hess, M.D., director of UF’s Movement Disorders Fellowship Program, and Adam Woods, Ph.D.,assistant director of the UF Center for Cognitive Aging and Memory Clinical Translational Research (CAM Center) and director of the Woods Neuromodulation Lab.
The randomized control trial involves transcranial and intranasal delivery of low-level, near-infrared (NIR) photobiomodulation over a two-week period. Effects will be tested by neuroimaging procedures, including magnetic resonance imaging (MRI) and MRS (magnetic resonance spectroscopy).
The intervention is based on positive neuroprotective and disease modifying effects of near infrared (NIR) stimulation in parkinsonian animal models and pilot trials in healthy older adults.
Parkinson’s Foundation Impact Awards support “outside the box” projects with the goal of bringing new light to the biology of Parkinson’s, or testing a truly novel therapeutic idea.